NRXS
Neuraxis, INC
NASDAQ · Healthcare · Biotechnology · US
$7.61
−0.26%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 24.13x
- P/S forward
- 7.90x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 14.19x
- Price / sales
- 17.98x
- Price / cash flow
- -17.00x
Enterprise value
- Enterprise value
- $87.5M
- EV / sales
- 16.46x
- EV / EBITDA
- -11.67x
- EV / EBIT
- -11.39x
- Market cap
- $95.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026